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Pretransplant Xenogeneic Blood Transfusion Combined With FK 506 
Prolongs Hamster-to-Rat Liver Xenograft Survival 
B. Nardo, L.A. Valdivia, F. Pan, S. Celli, M. Tsugita, AJ. Demetris, J.J. Fung, and T.E. Starzl 
I T IS KNOWN that donor-specific transfusion (DST) 
enhances graft survival in clinical transplantation. 
However, efforts using xenogeneic DST to improve xen-
ograft survival have resulted in hyperacute rejection 
(HAR) even in the presence of conventional immunosup-
pression. 1 In this study. we tested the effect of DST 
combined with FK 506 on survival of hamster-to-rat liver 
xenografts. L VG hamsters were the donors and LEW rats 
the recipients of orthotopic liver transplants. DST in the 
form of 1 mL of hamster whole blood was given IV on day 
-7. FK 506 was given in a dose of 1 mg/kg per day from 
day -7 to day -1. Liver grafting was done on day O. Liver 
xenograft survival is shown in Table I. 
DST alone induced high levels of antihamster antibodies 
on day 0, followed by HAR. Although the addition of FK 
506 caused minimal suppression in this response. HAR 
was avoided. Hamster lymphocytes were detected on day 
o in the spleen of LEW rats treated with DST + FK 506, 
but not in the spleens of rats treated with DST alone. 
In conclusion. the combination of DST plus FK 506 
avoided the hyperacute rejection caused by DST alone and 
resulted in a trend to longer liver xenograft survival. The 
presence of chimerism at the time of transplantation may 
be an advantage for longer graft survival. 
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Table 1. Survival of LIver Xenograft Recipients After OST Plus FK 506 Treatment 
Treatment n Graft Survival Days MST p 
1. None 8 6. 7. 7. 7. 7. 7. 7. 8 7.0:t 0.5 
2.DST 6 1. 1. 1. 2. 2. 3 1.6:t 0.8 <.01 vs Gl 
3. FK 506 1 mglkg per day 10 8.11.12.14,20.24,25.42. 26.2:t 17.7 <.01 vs Gl 
from - 7 d to -1 d 43.63 
4. DST + FK 506 10 12,22,22.24,25.37.49.74. 42.1 :t 25.8 NS vs G3 
74. 76 
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